200 related articles for article (PubMed ID: 36966941)
1. ARBM101 (Methanobactin SB2) Drains Excess Liver Copper via Biliary Excretion in Wilson's Disease Rats.
Einer C; Munk DE; Park E; Akdogan B; Nagel J; Lichtmannegger J; Eberhagen C; Rieder T; Vendelbo MH; Michalke B; Wimmer R; Blutke A; Feuchtinger A; Dershwitz P; DiSpirito AM; Islam T; Castro RE; Min BK; Kim T; Choi S; Kim D; Jung C; Lee H; Park D; Im W; Eun SY; Cho YH; Semrau JD; Rodrigues CMP; Hohenester S; Damgaard Sandahl T; DiSpirito AA; Zischka H
Gastroenterology; 2023 Jul; 165(1):187-200.e7. PubMed ID: 36966941
[TBL] [Abstract][Full Text] [Related]
2. High spatial resolution LA-ICP-MS demonstrates massive liver copper depletion in Wilson disease rats upon Methanobactin treatment.
Müller JC; Lichtmannegger J; Zischka H; Sperling M; Karst U
J Trace Elem Med Biol; 2018 Sep; 49():119-127. PubMed ID: 29895360
[TBL] [Abstract][Full Text] [Related]
3. Constructing "smart" chelators by using an activatable prochelator strategy for the treatment of Wilson's disease.
Wang C; Wang R; Zhao L; Wang S; Liu Y; Zhao J; Dong Y; Liu L; Wei P; Wu ZY; Yi T
Redox Biol; 2024 Apr; 70():103076. PubMed ID: 38340635
[TBL] [Abstract][Full Text] [Related]
4. Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models.
Zischka H; Lichtmannegger J
Ann N Y Acad Sci; 2014 May; 1315():6-15. PubMed ID: 24517326
[TBL] [Abstract][Full Text] [Related]
5. Methanobactin reverses acute liver failure in a rat model of Wilson disease.
Lichtmannegger J; Leitzinger C; Wimmer R; Schmitt S; Schulz S; Kabiri Y; Eberhagen C; Rieder T; Janik D; Neff F; Straub BK; Schirmacher P; DiSpirito AA; Bandow N; Baral BS; Flatley A; Kremmer E; Denk G; Reiter FP; Hohenester S; Eckardt-Schupp F; Dencher NA; Adamski J; Sauer V; Niemietz C; Schmidt HH; Merle U; Gotthardt DN; Kroemer G; Weiss KH; Zischka H
J Clin Invest; 2016 Jul; 126(7):2721-35. PubMed ID: 27322060
[TBL] [Abstract][Full Text] [Related]
6. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.
Weiss KH; Askari FK; Czlonkowska A; Ferenci P; Bronstein JM; Bega D; Ala A; Nicholl D; Flint S; Olsson L; Plitz T; Bjartmar C; Schilsky ML
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):869-876. PubMed ID: 28988934
[TBL] [Abstract][Full Text] [Related]
7. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
8. DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease.
Krishnan N; Felice C; Rivera K; Pappin DJ; Tonks NK
Genes Dev; 2018 Jul; 32(13-14):944-952. PubMed ID: 29945887
[TBL] [Abstract][Full Text] [Related]
9. The link between copper and Wilson's disease.
Purchase R
Sci Prog; 2013; 96(Pt 3):213-23. PubMed ID: 24244969
[TBL] [Abstract][Full Text] [Related]
10. 1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.
Xu J; Jiang H; Li J; Cheng KK; Dong J; Chen Z
PLoS One; 2015; 10(4):e0119654. PubMed ID: 25849323
[TBL] [Abstract][Full Text] [Related]
11. Demonstrating Potential of Cell Therapy for Wilson's Disease with the Long-Evans Cinnamon Rat Model.
Jaber FL; Sharma Y; Gupta S
Methods Mol Biol; 2017; 1506():161-178. PubMed ID: 27830552
[TBL] [Abstract][Full Text] [Related]
12. Wilson's disease: A 2017 update.
Poujois A; Woimant F
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):512-520. PubMed ID: 29625923
[TBL] [Abstract][Full Text] [Related]
13. Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
Hachmöller O; Zibert A; Zischka H; Sperling M; Groba SR; Grünewald I; Wardelmann E; Schmidt HH; Karst U
J Trace Elem Med Biol; 2017 Dec; 44():26-31. PubMed ID: 28965585
[TBL] [Abstract][Full Text] [Related]
14. The Role of Zinc in the Treatment of Wilson's Disease.
Avan A; Członkowska A; Gaskin S; Granzotto A; Sensi SL; Hoogenraad TU
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012580
[TBL] [Abstract][Full Text] [Related]
15. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
Purchase R
Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
[TBL] [Abstract][Full Text] [Related]
16. Wilson's disease: clinical, genetic and pharmacological findings.
Leggio L; Addolorato G; Abenavoli L; Gasbarrini G
Int J Immunopathol Pharmacol; 2005; 18(1):7-14. PubMed ID: 15698506
[TBL] [Abstract][Full Text] [Related]
17. Wilson's disease: Prospective developments towards new therapies.
Ranucci G; Polishchuck R; Iorio R
World J Gastroenterol; 2017 Aug; 23(30):5451-5456. PubMed ID: 28852304
[TBL] [Abstract][Full Text] [Related]
18. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
20. Wilson's disease: overview.
Lucena-Valera A; Ruz-Zafra P; Ampuero J
Med Clin (Barc); 2023 Mar; 160(6):261-267. PubMed ID: 36697289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
